Harada M - Search Results

1

Hypercalcemia-leukocytosis syndrome associated with lung cancer.

Hiraki A, Ueoka H, Takata I, Gemba K, Bessho A, Segawa Y, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M. Hiraki A, et al. Among authors: harada m. Lung Cancer. 2004 Mar;43(3):301-7. doi: 10.1016/j.lungcan.2003.09.006. Lung Cancer. 2004. PMID: 15165088

2

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.

Kawai H, Kiura K, Tabata M, Yoshino T, Takata I, Hiraki A, Chikamori K, Ueoka H, Tanimoto M, Harada M. Kawai H, et al. Among authors: harada m. Lung Cancer. 2002 Mar;35(3):305-14. doi: 10.1016/s0169-5002(01)00430-5. Lung Cancer. 2002. PMID: 11844606

3

Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.

Hiraki A, Kiura K, Yamane H, Nogami N, Tabata M, Takigawa N, Ueoka H, Tanimoto M, Harada M. Hiraki A, et al. Among authors: harada m. Lung Cancer. 2002 Mar;35(3):329-33. doi: 10.1016/s0169-5002(01)00424-x. Lung Cancer. 2002. PMID: 11844609

4

Gingival metastasis in lung cancer.

Tanaka M, Hiraki A, Ueoka H, Bessho A, Kiura K, Takigawa N, Kodani T, Miyatake K, Hamada N, Kishimoto T, Tanimoto M, Harada M. Tanaka M, et al. Among authors: harada m. Oncol Rep. 2002 May-Jun;9(3):571-4. Oncol Rep. 2002. PMID: 11956629

5

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.

Kodani T, Ueoka H, Kiura K, Tabata M, Takigawa N, Segawa Y, Moritaka T, Hiraki S, Harada M, Tanimoto M. Kodani T, et al. Among authors: harada m. Lung Cancer. 2002 Jun;36(3):313-9. doi: 10.1016/s0169-5002(02)00008-9. Lung Cancer. 2002. PMID: 12009244 Clinical Trial.

6

Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.

Hiraki A, Ueoka H, Bessho A, Segawa Y, Takigawa N, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M. Hiraki A, et al. Among authors: harada m. Cancer. 2002 Oct 15;95(8):1706-13. doi: 10.1002/cncr.10828. Cancer. 2002. PMID: 12365018 Free article.

7

[High dose chemotherapy with autologous peripheral blood stem cell transplantation in lung cancer].

Kiura K, Harada M. Kiura K, et al. Among authors: harada m. Nihon Rinsho. 2002 May;60 Suppl 5:463-8. Nihon Rinsho. 2002. PMID: 12101716 Review. Japanese. No abstract available.

8

Gastric perforation due to metastasis from adenocarcinoma of the lung.

Suzaki N, Hiraki A, Ueoka H, Aoe M, Takigawa N, Kishino T, Kiura K, Kanehiro A, Tanimoto M, Harada M. Suzaki N, et al. Among authors: harada m. Anticancer Res. 2002 Mar-Apr;22(2B):1209-12. Anticancer Res. 2002. PMID: 12168927

9

Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer.

Takata I, Ueoka H, Kiura K, Tabata M, Takigawa N, Katayama H, Takemoto M, Hiraki Y, Harada M, Tanimoto M. Takata I, et al. Among authors: harada m. Acta Med Okayama. 2002 Oct;56(5):261-6. doi: 10.18926/AMO/31705. Acta Med Okayama. 2002. PMID: 12530510 Free article. Clinical Trial.

10

Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.

Takigawa N, Fujiwara K, Ueoka H, Kiura K, Tabata M, Hiraki A, Shibayama T, Segawa Y, Kamei H, Hiraki S, Tanimoto M, Harada M. Takigawa N, et al. Among authors: harada m. Anticancer Res. 2003 Jan-Feb;23(1B):557-60. Anticancer Res. 2003. PMID: 12680145 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,912 results

Search Page

Filters